Rimonabant: more than an anti-obesity drug
Rimonabant is a selective cannabinoid CB1 receptor antagonist that has undergone extensive testing in the treatment of obesity in human subjects. The story of rimonabant as an anti-obesity compound begins with the understanding that the endocannabinoid system (cannabinoid receptors and their endogenous ligands) plays a significant role in stimulating ...
Comments Off